SCHEMBL2492227

SCHEMBL2492227

[CH2]c1ccc(-c2ccccc2)c(-c2ccccc2)c1NC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 1/20 0.36
ESR2 Q92731 1/20 0.35
PLK1 P53350 1/20 0.35
ALOX5 P09917 1/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPK1 P28482 1/20 0.34
MMP14 P50281 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSP90AB1 P08238 1/20 0.33
TSHR P16473 1/20 0.32
BRD4 O60885 1/20 0.32
BRD2 P25440 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
PTGS1 P23219 1/20 0.31
PTGS2 P35354 1/20 0.31
BACE1 P56817 1/20 0.30
PDE4B Q07343 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492089 0.81 SMN1; SMN2 (0.38) ESR2ALOX5MAPTMAPK1SMN1; SMN2
SCHEMBL2491950 0.78 LMNA (0.38) MAPTKDM4ELMNA
SCHEMBL2492803 0.76 TLR8 (0.41) MAPTKDM4EMAPK1SMN1; SMN2TDP1
SCHEMBL4870784 0.76 LMNA (0.39) ESR2ALOX5MAPTMAPK1BRD4
SCHEMBL2490178 0.75 BRD4 (0.38) ESR2ALOX5MAPTHSP90AB1BRD4
SCHEMBL2489466 0.71 ALOX5AP (0.35) ALOX5MAPTMAPK1LMNAHTT
SCHEMBL2492329 0.71 HDAC4 (0.45) ESR2ALOX5MAPTHSP90AB1LMNA
SCHEMBL2489246 0.70 MAPT (0.39) ESR2ALOX5MAPTKDM4ESMN1; SMN2
SCHEMBL2491463 0.70 GCGR (0.44) ESR2MAPTKDM4ESMN1; SMN2BRD4
SCHEMBL2492749 0.70 PDE4B (0.47) MAPTKDM4EMAPK1SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH TDO2 66/4885ESR2 3511/4885PLK1 4561/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 TDO2 56/4885ESR2 3465/4885PLK1 4642/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R TDO2 58/4885ESR2 3449/4885PLK1 4578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.